CompletedNot Applicable

Dorsal Root Ganglion Thermal Radiofrequency Versus Pulsed Radiofrequency for Metastatic Pain in Thoracic Vertebral Body

Egypt69 participantsStarted 2017-02-14

Plain-language summary

AIM OF THE WORK To evaluate the effectiveness and safety of Pulsed and Thermal Radiofrequency lesion of the dorsal root ganglion (RF-DRG) on a consecutive group of patients presenting with chronic thoracic pain due to vertebral bone metastasis.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. A greater than 6-month history of segmental pain of thoracic vertebral body metastasis origin.
. Unsatisfactory pain control with oral pharmacotherapy including strong opioid with VAS \>5 .
. Absence of a chronic or progressive motor deficit.
. Absence of significant sensory deficit.
. No indication for percutaneous or open surgical intervention.
. Magnetic resonance imaging and Computed Tomogrophy evidence of thoracic involvement.
. ASA status of II to III .

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

The European Organisation for Research and Treatment of Cancer (EORTC) Questionnaire to Measure Change in the Intensity of Pain QLQ-C30

Timeframe: Assessment done at 3 months after the procedure.

EORTC QLQ-BM22

Timeframe: Assessment done at 3 months after the procedure.

Visual Analog Scale (VAS), to Evaluate Pain

Timeframe: Assessment of pain done at 3 months after the procedure.

Oswestry Low Back Pain Disability Questionnaire (ODI),

Timeframe: Assessment of pain done at 3 months after the procedure.

Trial details

NCT IDNCT03204942

SponsorNational Cancer Institute, Egypt

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-07-30

Results submitted2019-09-27

View on ClinicalTrials.gov More Bone Neoplasm,Malignant Vertebral Column Thoracic Secondary trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. A greater than 6-month history of segmental pain of thoracic vertebral body metastasis origin.
. Unsatisfactory pain control with oral pharmacotherapy including strong opioid with VAS \>5 .
. Absence of a chronic or progressive motor deficit.
. Absence of significant sensory deficit.
. No indication for percutaneous or open surgical intervention.
. Magnetic resonance imaging and Computed Tomogrophy evidence of thoracic involvement.
. ASA status of II to III .

What they're measuring

The European Organisation for Research and Treatment of Cancer (EORTC) Questionnaire to Measure Change in the Intensity of Pain QLQ-C30

Timeframe: Assessment done at 3 months after the procedure.

EORTC QLQ-BM22

Timeframe: Assessment done at 3 months after the procedure.

Visual Analog Scale (VAS), to Evaluate Pain

Timeframe: Assessment of pain done at 3 months after the procedure.

Oswestry Low Back Pain Disability Questionnaire (ODI),

Timeframe: Assessment of pain done at 3 months after the procedure.

Dorsal Root Ganglion Thermal Radiofrequency Versus Pulsed Radiofrequency for Metastatic Pain in Thoracic Vertebral Body

Plain-language summary

Who can participate

Inclusion criteria

Questions worth asking your doctor

Questions for the trial coordinator

What they're measuring

Trial details

Dorsal Root Ganglion Thermal Radiofrequency Versus Pulsed Radiofrequency for Metastatic Pain in Thoracic Vertebral Body

Plain-language summary

Who can participate

Inclusion criteria

Questions worth asking your doctor

Questions for the trial coordinator

What they're measuring

Trial details

Exclusion criteria